Reengineering Redox Sensitive GFP to Measure Mycothiol Redox Potential of Mycobacterium tuberculosis during Infection

PLoS Pathogens

Volumn 10, Issue 1, 2014, Pages

  Bhaskar, Ashima ^a   Chawla, Manbeena ^a   Mehta, Mansi ^a   Parikh, Pankti ^a   Chandra, Pallavi ^a   Bhave, Devayani ^b   Kumar, Dhiraj ^a   Carroll, Kate S ^b   Singh, Amit ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GLYCOPEPTIDE; GREEN FLUORESCENT PROTEIN; INOSITOL; MYCOTHIOL;

BIOSYNTHESIS; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; OXIDATION REDUCTION REACTION; PATHOLOGY; PROTEIN ENGINEERING; TUBERCULOSIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CYSTEINE; GLYCOPEPTIDES; GREEN FLUORESCENT PROTEINS; HUMANS; INOSITOL; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; OXIDATION-REDUCTION; PROTEIN ENGINEERING; TUBERCULOSIS;

EID: 84893730144     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003902     Document Type: Article

References (74)

1. Dye C, Williams BG, (2010) The population dynamics and control of tuberculosis. Science 328: 856-861.
2. Ehrt S, Schnappinger D, (2009) Mycobacterial survival strategies in the phagosome: defence against host stresses. Cell Microbiol 11: 1170-1178.
3. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, et al. (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 94: 5243-5248.
4. Cooper AM, Segal BH, Frank AA, Holland SM, Orme IM, (2000) Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. Infect Immun 68: 1231-1234.
5. Lee PP, Chan KW, Jiang L, Chen T, Li C, et al. (2008) Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J 27: 224-230.
6. Yang CT, Cambier CJ, Davis JM, Hall CJ, Crosier PS, et al. (2012) Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe 12: 301-312.
7. den Hengst CD, Buttner MJ, (2008) Redox control in actinobacteria. Biochim Biophys Acta 1780: 1201-1216.
8. Brugarolas P, Movahedzadeh F, Wang Y, Zhang N, Bartek IL, et al. (2012) The oxidation-sensing regulator (MosR) is a new redox-dependent transcription factor in Mycobacterium tuberculosis. J Biol Chem 287: 37703-37712.
9. Singh A, Guidry L, Narasimhulu KV, Mai D, Trombley J, et al. (2007) Mycobacterium tuberculosis WhiB3 responds to O2 and nitric oxide via its [4Fe-4S] cluster and is essential for nutrient starvation survival. Proc Natl Acad Sci U S A 104: 11562-11567.
10. Singh A, Crossman DK, Mai D, Guidry L, Voskuil MI, et al. (2009) Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response. PLoS Pathog 5: e1000545.
11. Chawla M, Parikh P, Saxena A, Munshi M, Mehta M, et al. (2012) Mycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo. Mol Microbiol 85: 1148-1165.
12. Song T, Dove SL, Lee KH, Husson RN, (2003) RshA, an anti-sigma factor that regulates the activity of the mycobacterial stress response sigma factor SigH. Mol Microbiol 50: 949-959.
13. Flynn JL, Chan J, (2001) Tuberculosis: latency and reactivation. Infect Immun 69: 4195-4201.
14. Kumar A, Farhana A, Guidry L, Saini V, Hondalus M, et al. (2011) Redox homeostasis in mycobacteria: the key to tuberculosis control? Expert Rev Mol Med 13: e39.
15. Rota C, Chignell CF, Mason RP, (1999) Evidence for free radical formation during the oxidation of 2′-7′-dichlorofluorescin to the fluorescent dye 2′-7′-dichlorofluorescein by horseradish peroxidase: possible implications for oxidative stress measurements. Free Radic Biol Med 27: 873-881.
16. Tarpey MM, Wink DA, Grisham MB, (2004) Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 286: R431-444.
17. Meyer AJ, Dick TP, (2010) Fluorescent protein-based redox probes. Antioxid Redox Signal 13: 621-650.
18. Newton GL, Rawat M, La Clair JJ, Jothivasan VK, Budiarto T, et al. (2009) Bacillithiol is an antioxidant thiol produced in Bacilli. Nat Chem Biol 5: 625-627.
19. Jothivasan VK, Hamilton CJ, (2008) Mycothiol: synthesis, biosynthesis and biological functions of the major low molecular weight thiol in actinomycetes. Nat Prod Rep 25: 1091-1117.
20. Sareen D, Newton GL, Fahey RC, Buchmeier NA, (2003) Mycothiol is essential for growth of Mycobacterium tuberculosis Erdman. J Bacteriol 185: 6736-6740.
21. Buchmeier NA, Newton GL, Koledin T, Fahey RC, (2003) Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics. Mol Microbiol 47: 1723-1732.
22. Hanson GT, Aggeler R, Oglesbee D, Cannon M, Capaldi RA, et al. (2004) Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem 279: 13044-13053.
23. Meyer AJ, Brach T, Marty L, Kreye S, Rouhier N, et al. (2007) Redox-sensitive GFP in Arabidopsis thaliana is a quantitative biosensor for the redox potential of the cellular glutathione redox buffer. Plant J 52: 973-986.
24. Gutscher M, Pauleau AL, Marty L, Brach T, Wabnitz GH, et al. (2008) Real-time imaging of the intracellular glutathione redox potential. Nat Methods 5: 553-559.
25. Van Laer K, Buts L, Foloppe N, Vertommen D, Van Belle K, et al. (2012) Mycoredoxin-1 is one of the missing links in the oxidative stress defence mechanism of Mycobacteria. Mol Microbiol 86: 787-804.
26. Rawat M, Newton GL, Ko M, Martinez GJ, Fahey RC, et al. (2002) Mycothiol-deficient Mycobacterium smegmatis mutants are hypersensitive to alkylating agents, free radicals, and antibiotics. Antimicrob Agents Chemother 46: 3348-3355.
27. Patel MP, Blanchard JS, (1999) Expression, purification, and characterization of Mycobacterium tuberculosis mycothione reductase. Biochemistry 38: 11827-11833.
28. Gutierrez-Lugo MT, Baker H, Shiloach J, Boshoff H, Bewley CA, (2009) Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening. J Biomol Screen 14: 643-652.
29. Arner ES, Nakamura H, Sasada T, Yodoi J, Holmgren A, et al. (2001) Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex. Free Radic Biol Med 31: 1170-1178.
30. Haramaki N, Han D, Handelman GJ, Tritschler HJ, Packer L, (1997) Cytosolic and mitochondrial systems for NADH- and NADPH-dependent reduction of alpha-lipoic acid. Free Radic Biol Med 22: 535-542.
31. Rawat M, Johnson C, Cadiz V, Av-Gay Y, (2007) Comparative analysis of mutants in the mycothiol biosynthesis pathway in Mycobacterium smegmatis. Biochem Biophys Res Commun 363: 71-76.
32. Fernandes ND, Wu QL, Kong D, Puyang X, Garg S, et al. (1999) A mycobacterial extracytoplasmic sigma factor involved in survival following heat shock and oxidative stress. J Bacteriol 181: 4266-4274.
33. Raman S, Song T, Puyang X, Bardarov S, Jacobs WR Jr, et al. (2001) The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. J Bacteriol 183: 6119-6125.
34. Kaushal D, Schroeder BG, Tyagi S, Yoshimatsu T, Scott C, et al. (2002) Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc Natl Acad Sci U S A 99: 8330-8335.
35. Newton GL, Ta P, Fahey RC, (2005) A mycothiol synthase mutant of Mycobacterium smegmatis produces novel thiols and has an altered thiol redox status. J Bacteriol 187: 7309-7316.
36. Ta P, Buchmeier N, Newton GL, Rawat M, Fahey RC, (2011) Organic hydroperoxide resistance protein and ergothioneine compensate for loss of mycothiol in Mycobacterium smegmatis mutants. J Bacteriol 193: 1981-1990.
37. Holsclaw CM, Muse WB 3rd, Carroll KS, Leary JA, (2011) Mass Spectrometric Analysis of Mycothiol levels in Wild-Type and Mycothiol Disulfide Reductase Mutant Mycobacterium smegmatis. Int J Mass Spectrom 305: 151-156.
38. Albrecht SC, Barata AG, Grosshans J, Teleman AA, Dick TP, (2011) In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis. Cell Metab 14: 819-829.
39. Ung KS, Av-Gay Y, (2006) Mycothiol-dependent mycobacterial response to oxidative stress. FEBS Lett 580: 2712-2716.
40. Chan J, Xing Y, Magliozzo RS, Bloom BR, (1992) Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175: 1111-1122.
41. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR, (1995) Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 63: 736-740.
42. Rohde KH, Veiga DF, Caldwell S, Balazsi G, Russell DG, (2012) Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection. PLoS Pathog 8: e1002769.
43. Liu YB, Long MX, Yin YJ, Si MR, Zhang L, et al. (2013) Physiological roles of mycothiol in detoxification and tolerance to multiple poisonous chemicals in Corynebacterium glutamicum. Arch Microbiol 195: 419-29.
44. Rawat M, Uppal M, Newton G, Steffek M, Fahey RC, et al. (2004) Targeted mutagenesis of the Mycobacterium smegmatis mca gene, encoding a mycothiol-dependent detoxification protein. J Bacteriol 186: 6050-6058.
45. Xu X, Vilcheze C, Av-Gay Y, Gomez-Velasco A, Jacobs WR Jr, (2011) Precise null deletion mutations of the mycothiol synthesis genes reveal their role in isoniazid and ethionamide resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother 55: 3133-3139.
46. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W, (2011) Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 55: 355-360.
47. Yano T, Kassovska-Bratinova S, Teh JS, Winkler J, Sullivan K, et al. (2011) Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J Biol Chem 286: 10276-10287.
48. Connolly LE, Edelstein PH, Ramakrishnan L, (2007) Why is long-term therapy required to cure tuberculosis? PLoS Med 4: e120.
49. Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, et al. (2011) Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145: 39-53.
50. Hewitt CJ, Nebe-Von-Caron G, (2001) An industrial application of multiparameter flow cytometry: assessment of cell physiological state and its application to the study of microbial fermentations. Cytometry 44: 179-187.
51. Gutscher M, Sobotta MC, Wabnitz GH, Ballikaya S, Meyer AJ, et al. (2009) Proximity-based protein thiol oxidation by H2O2-scavenging peroxidases. J Biol Chem 284: 31532-31540.
52. Welin A, Raffetseder J, Eklund D, Stendahl O, Lerm M, (2011) Importance of phagosomal functionality for growth restriction of Mycobacterium tuberculosis in primary human macrophages. J Innate Immun 3: 508-518.
53. Clemens DL, Horwitz MA, (1996) The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med 184: 1349-1355.
54. Russell DG, Mwandumba HC, Rhoades EE, (2002) Mycobacterium and the coat of many lipids. J Cell Biol 158: 421-426.
55. Homolka S, Niemann S, Russell DG, Rohde KH, (2010) Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog 6: e1000988.
56. Koo MS, Subbian S, Kaplan G, (2012) Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages. Cell Commun Signal 10: 2.
57. Manca C, Paul S, Barry CE 3rd, Freedman VH, Kaplan G, (1999) Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun 67: 74-79.
58. Idh J, Mekonnen M, Abate E, Wedajo W, Werngren J, et al. (2012) Resistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosis. PLoS One 7: e39891.
59. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ, (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810.
60. Dwyer DJ, Kohanski MA, Collins JJ, (2009) Role of reactive oxygen species in antibiotic action and resistance. Curr Opin Microbiol 12: 482-489.
61. Brynildsen MP, Winkler JA, Spina CS, Macdonald IC, Collins JJ, (2013) Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production. Nat Biotechnol 31: 160-165.
62. Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K, (2013) Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339: 1213-1216.
63. Liu Y, Imlay JA, (2013) Cell death from antibiotics without the involvement of reactive oxygen species. Science 339: 1210-1213.
64. Sao Emani C, Williams MJ, Wiid IJ, Hiten NF, Viljoen AJ, et al. (2013) Ergothioneine is a secreted antioxidant in Mycobacterium smegmatis. Antimicrob Agents Chemother 57L: 3202-7.
65. Kim JJ, Lee HM, Shin DM, Kim W, Yuk JM, et al. (2012) Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. Cell Host Microbe 11: 457-468.
66. Vilcheze C, Av-Gay Y, Attarian R, Liu Z, Hazbon MH, et al. (2008) Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Mol Microbiol 69: 1316-1329.
67. Russell DG, VanderVen BC, Lee W, Abramovitch RB, Kim MJ, et al. (2010) Mycobacterium tuberculosis wears what it eats. Cell Host Microbe 8: 68-76.
68. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, et al. (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76: 2333-2340.
69. Boshoff HI, Xu X, Tahlan K, Dowd CS, Pethe K, et al. (2008) Biosynthesis and recycling of nicotinamide cofactors in Mycobacterium tuberculosis. An essential role for NAD in nonreplicating bacilli. J Biol Chem 283: 19329-19341.
70. Lin PL, Dartois V, Johnston PJ, Janssen C, Via L, et al. (2012) Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques. Proc Natl Acad Sci U S A 109: 14188-14193.
71. Grant SS, Kaufmann BB, Chand NS, Haseley N, Hung DT, (2012) Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc Natl Acad Sci U S A 109: 12147-12152.
72. Fortune SM, (2012) The Surprising Diversity of Mycobacterium tuberculosis: Change You Can Believe In. J Infect Dis 206: 1642-1644.
73. Rankin S, Li Z, Isberg RR, (2002) Macrophage-induced genes of Legionella pneumophila: protection from reactive intermediates and solute imbalance during intracellular growth. Infect Immun 70: 3637-3648.
74. Singh A, Mai D, Kumar A, Steyn AJ, (2006) Dissecting virulence pathways of Mycobacterium tuberculosis through protein-protein association. Proc Natl Acad Sci U S A 103: 11346-11351.